BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1294 related articles for article (PubMed ID: 16989071)

  • 1. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection with calcium antagonism in essential hypertension.
    Bauer JH; Reams GP
    Clin Invest Med; 1989 Oct; 12(5):300-4. PubMed ID: 2689026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension with co-existing renal disease.
    Bauer JH; Reams GP
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():27-34. PubMed ID: 2090835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of antihypertensive agents on proteinuria and renal function.
    Maki DD; Ma JZ; Louis TA; Kasiske BL
    Arch Intern Med; 1995 May; 155(10):1073-80. PubMed ID: 7748051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S51-4. PubMed ID: 16989065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antihypertensive therapy on renal function.
    Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal actions of calcium antagonists.
    Sterzel RB
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S17-22. PubMed ID: 2455125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertension in renal parenchymal diseases].
    Iversen BM; Kvam FI; Svarstad E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renin-angiotensin system in the regulation of glomerular filtration.
    Sraer JD; Kanfer A; Rondeau E; Lacave R
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S21-5. PubMed ID: 2483424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of anti-hypertensive drugs on glomerular hemodynamics.
    Ito S; Abe K
    Nihon Jinzo Gakkai Shi; 1996 Mar; 38(3):115-8. PubMed ID: 8721331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
    Segura J; GarcĂ­a-Donaire JA; Ruilope LM
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):422-6. PubMed ID: 17693756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy and mobilization of renal functional reserve.
    Burnier M; Biollaz J; Steinhauslin F; Brouard R; Waeber B; Brunner HR
    Clin Invest Med; 1991 Dec; 14(6):581-9. PubMed ID: 1686579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.